Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance

Journal of the American College of Cardiology

Volumn 54, Issue 3, 2009, Pages 220-228

  Maron, Martin S ^a   Maron, Barry J ^b   Harrigan, Caitlin ^a   Buros, Jacki ^c   Gibson, C Michael ^c,d   Olivotto, Iacopo ^e   Biller, Leah ^b   Lesser, John R ^b   Udelson, James E ^a   Manning, Warren J ^c,d   Appelbaum, Evan ^c,d  

^a TUFTS MEDICAL CENTER   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

fibrosis; hypertrophic cardiomyopathy; hypertrophy; magnetic resonance imaging

Indexed keywords

GADOLINIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; GADOLINIUM; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDIES; TIME FACTORS; VENTRICULAR OUTFLOW OBSTRUCTION; YOUNG ADULT;

EID: 67649599134     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.05.006     Document Type: Article

References (38)

1. Maron B.J., McKenna W.J., Danielson G.K., et al. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines (Committee to Develop an Expert Consensus Document on Hypetrophic Cardiomyopathy). J Am Coll Cardiol 42 (2003) 1687-1713
2. Spirito P., Seidman C.E., McKenna W.J., and Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med 336 (1997) 775-785
3. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
4. Braunwald E., Lambrew C.T., Rockoff S.D., Ross Jr. J., and Morrow A.G. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation 30 Suppl 4 (1964) 3-119
5. Hughes S. The pathology of hypertrophic cardiomyopathy. Histopathology 44 (2004) 412-427
6. Klues H.G., Schiffers A., and Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26 (1995) 1699-1708
7. Maron B.J., Gottdiener J.S., and Epstein S.E. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 48 (1981) 418-428
8. Roberts C.S., and Roberts W.C. Morphologic features. Prog Cardiovasc Dis 2 (1989) 3-22
9. Rose A.G. Evaluation of pathological criteria for diagnosis of hypertrophic cardiomyopathy. Histopathology 8 (1984) 395-406
10. Shapiro L.M., and McKenna W.J. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 2 (1983) 437-444
11. Wigle E.D., Rakowski H., Kimball B.P., and Williams W.G. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 92 (1995) 1680-1692
12. Wigle E.D., Sasson Z., Henderson M.A., et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 28 (1985) 1-83
13. Davies M.J. The cardiomyopathies: an overview. Heart 83 (2000) 469-474
14. Maron B.J., Henry W.L., Roberts W.C., and Epstein S.E. Comparison of echocardiographic and necropsy measurements of ventricular wall thicknesses in patients with and without disproportionate septal thickening. Circulation 55 (1977) 341-346
15. Choudhury L., Mahrholdt H., Wagner A., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 2156-2164
16. Lima J.A., and Desai M.Y. Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol 44 (2004) 1164-1171
17. Maron M.S., Harrigan C., Buros J., et al. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 1 (2008) 184-191
18. Moon J.C., Fisher N.G., McKenna W.J., and Pennell D.J. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90 (2004) 645-649
19. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
20. Pennell D.J. Cardiovascular magnetic resonance: twenty-first century solutions in cardiology. Clin Med 3 (2003) 273-278
21. Rochitte C.E., Tassi E.M., and Shiozaki A.A. The emerging role of MRI in the diagnosis and management of cardiomyopathies. Curr Cardiol Rep 8 (2006) 44-52
22. Maron M.S., Olivotto I., Betocchi S., et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
23. Adabag A.S., Maron B.J., Appelbaum E., et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51 (2008) 1369-1374
24. Olivotto I., Maron M.S., Autore C., et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 52 (2008) 559-566
25. Grothues F., Smith G.C., Moon J.C., et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90 (2002) 29-34
26. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 18 (2002) 539-542
27. Maron M.S., Hauser T.H., Dubrow E., et al. Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol 100 (2007) 1293-1298
28. Harrigan C.J., Appelbaum E., Maron B.J., et al. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol 101 (2008) 668-673
29. Rickers C., Wilke N.M., Jerosch-Herold M., et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112 (2005) 855-861
30. Maron B.J., Haas T.S., and Lesser J.R. Images in cardiovascular medicine. Diagnostic utility of cardiac magnetic resonance imaging in monozygotic twins with hypertrophic cardiomyopathy and identical pattern of left ventricular hypertrophy. Circulation 115 (2007) e627-e628
31. Seidman J.G., and Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104 (2001) 557-567
32. Sherrid M.V., Chaudhry F.A., and Swistel D.G. Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg 75 (2003) 620-632
33. McCully R.B., Nishimura R.A., Tajik A.J., Schaff H.V., and Danielson G.K. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 94 (1996) 467-471
34. Maron B.J., Dearani J.A., Ommen S.R., et al. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 2044-2053
35. McIntosh C.L., and Maron B.J. Current operative treatment of obstructive hypertrophic cardiomyopathy. Circulation 78 (1988) 487-495
36. Lewis J.F., and Maron B.J. Diversity of patterns of hypertrophy in patients with systemic hypertension and marked left ventricular wall thickening. Am J Cardiol 65 (1990) 874-881
37. Valeti U.S., Nishimura R.A., Holmes D.R., et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 49 (2007) 350-357
38. Moon J.C., Reed E., Sheppard M.N., et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43 (2004) 2260-2264